| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.036 | 0.4 |